Genetic Testing

New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]

Emerging Tests

New Genomic Test Can Eliminate Up to One-Third of Medically Unnecessary Prostate Cancer Biopsies

Genetic testing has been shown to be effective in detecting prostate cancer and eliminating the need for unnecessary biopsies. And even though the current commercial market for such tests is crowded, … [Read more...]

Genetic Testing

New Study Shows Viability of Using Ancestry to Compare Prostate Cancer Risk Across Populations

Ancestry has been shown to be a risk factor for prostate cancer. Unfortunately, we know very little about why men of certain races and ethnicities are more prone to get it, let alone how to use … [Read more...]

The Quest Case and Medical Malpractice Liability Risks of Genetic Testing Labs

For years, Quest Diagnostics has been embroiled in a poignant lawsuit testing the liability of genetic labs for faulty DNA test results. In 2018, Quest struck a decisive blow by getting the South … [Read more...]

Genetic Testing

The Quest Case and Medical Malpractice Liability Risks of Genetic Testing Labs

For years, Quest Diagnostics has been embroiled in a poignant lawsuit testing the liability of genetic labs for faulty DNA test results. In 2018, Quest struck a decisive blow by getting the South … [Read more...]

Genetic Testing

New EMSO Guidelines Address Efficacy of Next Generation Sequencing for Different Cancer Types

The European Society for Medical Oncology (ESMO) recently issued guidelines on use of next-generation sequencing (NGS) for various types of cancer as part of routine clinical practice. The … [Read more...]

Data

Genomic Testing Utilization Is Low & Geographically Inconsistent but Not Just Due to Payor Coverage

Genomic testing is inconsistently utilized in the U.S., even in states with favorable coverage policies. Those are the findings of a report from the Personalized Medicine Coalition (PMC) released in … [Read more...]

Genetic Tests

New Guidelines Advise Against Using Polygenetic Risk Scores for Routine Patient Management

New guidelines from the National Comprehensive Cancer Network (NCCN) advise against using polygenetic risk scores for routine patient management and update previous recommendations for assessing … [Read more...]

Precision Medicine

New ACOG Guidelines Recommend cfDNA-Based NIPT for All Pregnancies, Not Just Risky Ones

The American College of Obstetricians and Gynecologists (ACOG) has revised its position on noninvasive prenatal testing (NIPT) and is now recommending prenatal aneuploidy screening for all pregnant … [Read more...]

Reimbursement

Payors Gradually Increasing Coverage of Liquid Biopsies but Obstacles Remain

Gaining the acceptance of insurers and payors for new tests and testing technology is a perennial challenge for laboratories and test developers. This has been especially true with liquid biopsy … [Read more...]


(-00000g2)